Technical Data
L1664-85A
(R,S)-Lenalidomide, Free Base (3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione, CC-5013, CDC-501, ENMD-0997, Revamid, Revimid)
25mg
Biochemicals Storage: -20CShipping: Blue Ice
Cell-permeable. An analog of thalidomide that was originally found based on its ability to effectively inhibit tumor necrosis factor production. Lenalidomide is 50,000 times more potent than thalidomide in inhibiting Tumor Necrosis Factor-a (TNF-a). Displays potent anti-tumor and anti-inflammatory effects as well as modulates and potentiates host immune responses against multiple myeloma.

Solubility:
DMSO (~100mg/ml)

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with DMSO. Aliquot to avoid repeated freezing and thawing. Store at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

CAS Number:
191732-72-6

Molecular Formula:
C H N O

Molecular Weight:
259.26
Purity: ~98% (HPLC)
Form: Supplied as a white to off-white solid

Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.